Chris Garabedian, Managing Director at Xontogeny, Boston, Massachusetts, United States — verified investor profile. See contact routes.
Xontogeny is a life sciences accelerator that collaborates with entrepreneurs, scientific founders, and first-time CEOs to develop technologies for new treatment options for patients with serious disease. They offer seed investment capital across therapeutics, diagnostics, and devices, aiming to shepherd each program through a compelling clinical proof-of-concept study. They make seed investments and incubate early-stage life sciences companies across various modalities and therapeutic areas.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Boston when building a target list.
Investors like Chris Garabedian · Full investor directory · Investor access · Company funding database